Immunohistochemical profile for unknown primary adenocarcinoma. - Wikidata - wikimedia - TriplyDB

Immunohistochemical profile for unknown primary adenocarcinoma.

Immunohistochemical profile for unknown primary adenocarcinoma.

http://www.wikidata.org/entity/Q31047832

about

KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.Characteristics of additional primary malignancies in Korean patients with non-small cell lung cancer.A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary.A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site.Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.A systematic analysis of commonly used antibodies in cancer diagnostics.Occult Breast Carcinoma Presenting as Scalp Metastasis.Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.

P2860

Q33878516-76714CCA-D613-4D19-86CB-06CAF359ED31 Q37457338-78636BC0-62FD-4B69-B997-0EB4FEBA22A3 Q37607002-1598078B-59A0-4B54-8B17-1BD441391C2C Q38694763-097494E1-3310-471D-ADE6-05D7973A62A7 Q38940588-CFBFB8AE-00AB-4972-BFB0-3AED53F40329 Q39013175-CE2B1335-47AC-4820-8BC8-602CA336AB3E Q46602608-E09A454A-50CE-4B05-8B05-B6539B4D3E84 Q47135576-B5FB2634-ED64-4BBD-9B48-862E863006A7 Q49578351-9D5DB7FE-3EA7-43BA-A037-8E2B281BAFFD Q51320597-7B370940-55AB-4EE3-B36D-EBBDB0E7E453

P2860

Immunohistochemical profile for unknown primary adenocarcinoma.

http://www.wikidata.org/entity/Q31047832

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Immunohistochemical profile for unknown primary adenocarcinoma.

@ast

Immunohistochemical profile for unknown primary adenocarcinoma.

@en

type

label

Immunohistochemical profile for unknown primary adenocarcinoma.

@ast

Immunohistochemical profile for unknown primary adenocarcinoma.

@en

prefLabel

Immunohistochemical profile for unknown primary adenocarcinoma.

@ast

Immunohistochemical profile for unknown primary adenocarcinoma.

@en

P1433

Q31047832-8C6CDD1C-823D-4DF0-8F4A-7AEE20084A49

P1476

Q31047832-D51F9378-0477-4DDA-B24E-FE254059AB01

P2093

Q31047832-3C497767-7BBA-45DB-B9E4-4DFC9FA03DC8

Q31047832-3ED22C1D-C18E-4996-AE1A-45E8A29D864A

Q31047832-4579E3EB-946A-470D-BD48-2179DF2E7137

Q31047832-687B4748-3F4F-4EC4-8E6E-1BDF98A8E676

Q31047832-BADE1EB5-34A9-42BF-B234-2675A9612FDD

Q31047832-BED99E01-EE48-45F0-91A8-EA54660DBE56

Q31047832-DF855E96-9229-44C4-A691-8758E2F386FE

P2860

Q31047832-156EF59D-C4ED-453B-AC11-47D27B00B4D6

Q31047832-160A0A13-6151-43CC-BE8A-8AB17DAC73B9

Q31047832-22DFB109-EB06-45E4-9A88-C1E48EAC877F

Q31047832-2340DB7C-A7F9-4AE3-9E03-1CAC301FB0FE

Q31047832-2B0933E6-11FA-4377-9E6B-AF67912FAE62

Q31047832-37829CF6-7BFB-426F-9EAB-1CC6540FC8ED

Q31047832-5470977E-0DD7-4736-BA19-5D44F9317836

Q31047832-54C7531C-D832-4568-A192-C3520F7BC5ED

Q31047832-55542CB4-7601-4C01-8304-40E37D46F97D

Q31047832-70DCD15C-856F-48D7-88D6-CDE5A4BAF7D2

P304

Q31047832-52475727-D502-4D4A-B2E0-7CCA6EAAEA32

P31

Q31047832-63CF0DEC-B7A2-49CA-B81B-FFD64D2FF73C

P356

Q31047832-4B36AC1E-D2EB-4A12-9E68-F40E251CE6AD

P407

Q31047832-73264F21-91CC-462F-8368-6E31CD61395B

P433

Q31047832-0A7DBE31-4439-4C04-A74A-6931E5F9A388

P478

Q31047832-B7B12321-9E6E-4607-BBCA-BD0B888300AC

P50

Q31047832-E42F6CBF-F7EA-4C98-AC1E-2793291BE2D8

P577

Q31047832-12D2DE7D-79B6-4054-99DA-3113A4AE5DA3

P5875

Q31047832-423B8A79-D420-4874-825D-D675DBF0C970

P698

Q31047832-6847F470-DB5A-4F9A-ADF1-9AA1F52FE99D

P921

Q31047832-1AE92A3C-CF25-4A4E-BA76-E7B699117D08

Q31047832-59011CB7-0C25-48CB-8A45-6C3CD03AE055

P932

Q31047832-3E60934C-F557-43AE-9D39-6B10CAD74B4D

P356

JOURNAL.PONE.0031181

P1433

P1476

Immunohistochemical profile for unknown primary adenocarcinoma.

@en

P2093

Hitoshi Tsuda

http://www.w3.org/2001/XMLSchema#string

Kan Yonemori

http://www.w3.org/2001/XMLSchema#string

Kenji Hashimoto

http://www.w3.org/2001/XMLSchema#string

Koh Furuta

http://www.w3.org/2001/XMLSchema#string

Masashi Ando

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Fujiwara

http://www.w3.org/2001/XMLSchema#string

Yuko Sasajima

http://www.w3.org/2001/XMLSchema#string

P2860

Sorafenib in advanced hepatocellular carcinoma

Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site.

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).

Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis.

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.

Hybrid model integrating immunohistochemistry and expression profiling for the classification of carcinomas of unknown primary site.

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma.

Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.

P304

e31181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0031181

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Akihiro Hirakawa

P577

2012-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221800013

http://www.w3.org/2001/XMLSchema#string

P698

22299055

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

3267772

http://www.w3.org/2001/XMLSchema#string